As of 2025-10-20, the Relative Valuation of Surmodics Inc (SRDX) is (43.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 27.99 USD, the upside of Surmodics Inc based on Relative Valuation is -255.0%.
The range of the Relative Valuation is (35.48) - (44.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.8x - 42.5x | 37.7x |
| Forward P/E multiples | 27.4x - 35.7x | 32.8x |
| Fair Price | (35.48) - (44.01) | (43.39) |
| Upside | -226.7% - -257.2% | -255.0% |
| Date | P/E |
| 2025-10-16 | -22.72 |
| 2025-10-15 | -22.49 |
| 2025-10-14 | -22.38 |
| 2025-10-13 | -22.65 |
| 2025-10-10 | -23.23 |
| 2025-10-09 | -23.37 |
| 2025-10-08 | -23.29 |
| 2025-10-07 | -23.38 |
| 2025-10-06 | -23.28 |
| 2025-10-03 | -23.62 |
| 2025-10-02 | -24.26 |
| 2025-10-01 | -24.26 |
| 2025-09-30 | -24.25 |
| 2025-09-29 | -24.26 |
| 2025-09-26 | -24.29 |
| 2025-09-25 | -25.00 |
| 2025-09-24 | -24.71 |
| 2025-09-23 | -25.23 |
| 2025-09-22 | -26.10 |
| 2025-09-19 | -26.26 |
| 2025-09-18 | -26.14 |
| 2025-09-17 | -25.88 |
| 2025-09-16 | -25.90 |
| 2025-09-15 | -26.26 |
| 2025-09-12 | -25.93 |
| 2025-09-11 | -26.18 |
| 2025-09-10 | -26.06 |
| 2025-09-09 | -26.65 |
| 2025-09-08 | -26.71 |
| 2025-09-05 | -26.27 |
| 2025-09-04 | -27.09 |
| 2025-09-03 | -27.61 |
| 2025-09-02 | -27.86 |
| 2025-08-29 | -27.62 |
| 2025-08-28 | -27.85 |
| 2025-08-27 | -27.70 |
| 2025-08-26 | -28.14 |
| 2025-08-25 | -28.65 |
| 2025-08-22 | -30.17 |
| 2025-08-21 | -29.28 |
| 2025-08-20 | -29.94 |
| 2025-08-19 | -30.29 |
| 2025-08-18 | -29.93 |
| 2025-08-15 | -30.39 |
| 2025-08-14 | -30.54 |
| 2025-08-13 | -30.82 |
| 2025-08-12 | -30.76 |
| 2025-08-11 | -30.83 |
| 2025-08-08 | -28.73 |
| 2025-08-07 | -28.40 |